JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brunori, M.
Right arrow Articles by Wyman, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brunori, M.
Right arrow Articles by Wyman, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Studies on the Oxidation-Reduction Potentials of Heme Proteins

VII. OXIDATION-REDUCTION EQUILIBRIUM OF HEMOGLOBIN BOUND TO HAPTOGLOBIN

Maurizio Brunori 1, Annette Alfsen 1, Ughetta Saggese 1, Eraldo Antonini 1, and Jeffries Wyman 1

From the 1 From the Institute of Biochemistry, University of Rome, and Center for Molecular Biology of the National Research Council, Rome, and the Regina Elena Institute for Cancer Research, Rome, Italy

The oxidation-reduction equilibrium of human hemoglobin bound to haptoglobin has been investigated.

The genetic type of haptoglobin (whether 1-1 or 2-2) has no effect on the oxidation-reduction properties of bound hemoglobin.

The shape of the equilibrium curve changes with the molar ratio between haptoglobin and hemoglobin, being clearly asymmetrical when Hp:Hb = 1:1 and symmetrical when Hp:Hb = 2:1. The average value of n near 50% oxidation is less than 1 in either case.

When Hp:Hb = 2:1, the oxidation-reduction equilibrium curve can be accounted for quantitatively on the hypothesis that there are two oxidation-reduction systems present in equimolar amounts, and each is characterized by n = 1 but different midpoint potentials (E1 and E2). The interpretation of these results is that when hemoglobin is bound to haptoglobin the stabilizing heme-heme interactions are suppressed with the result that the hemes of each type of chain (agr and ß) display their intrinsic oxidation-reduction properties. The proposition that the oxidation-reduction potentials of agr and ß chains are different (by 56 mv at pH 7) is in good agreement with independent experimental results on human hemoglobin and the isolated hemoglobin chains.

The oxidation-reduction results taken alone indicate that when Hp:Hb = 2:1 only one type of complex is present. On the other hand, when Hp:Hb = 1:1 the equilibrium data suggest that more than one type of complex is formed, and that the two hemoglobin chains of either type (agr or ß) are not bound in the same way to the haptoglobin molecule.

Submitted on January 22, 1968


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. M. Faulkner, C. Bonaventura, and A. L. Crumbliss
A Spectroelectrochemical Method for Differentiation of Steric and Electronic Effects in Hemoglobins and Myoglobins
J. Biol. Chem., June 9, 1995; 270(23): 13604 - 13612.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1968 by the American Society for Biochemistry and Molecular Biology.